Ignite Creation Date:
2025-12-24 @ 10:07 PM
Ignite Modification Date:
2025-12-25 @ 7:43 PM
Study NCT ID:
NCT01428635
Status:
COMPLETED
Last Update Posted:
2023-09-26
First Post:
2011-09-01
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Eltrombopag Olamine in Treating Thrombocytopenia in Patients With Chronic Myeloid Leukemia or Myelofibrosis Receiving Tyrosine Kinase Therapy
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-01-13
Start Date Type:
ACTUAL
Primary Completion Date:
2022-01-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-01-03
Completion Date Type:
ACTUAL
First Submit Date:
2011-09-01
First Submit QC Date:
None
Study First Post Date:
2011-09-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2023-01-05
Results First Submit QC Date:
None
Results First Post Date:
2023-02-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-09-06
Last Update Post Date:
2023-09-26
Last Update Post Date Type:
ACTUAL